Carisma Therapeutics (CARM) - 2023 Q1 - Quarterly Report

Delaware 26-2025616 (State or other jurisdiction of incorporation or organization)(IRS Employer Identification No.) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR For the transition period from ___________________ to ___________________ Carisma Therapeutics Inc. (Exact Name of Registrant as Specified in its Charter) Registrant's telephone number, including area code: (267) 491-6422 Securitie ...